ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange

operates under Pharmaceuticals sector

Daily price and charts and targets GlaxosmithklinePharmaceuticals

Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2353.95 and 2461.65

Intraday Target 12266.27
Intraday Target 22333.93
Intraday Target 32373.9666666667
Intraday Target 42441.63
Intraday Target 52481.67

Daily price and volume Glaxosmithkline Pharmaceuticals

Date Closing Open Range Volume
Fri 30 January 2026 2401.60 (1.48%) 2359.90 2306.30 - 2414.00 1.4298 times
Thu 29 January 2026 2366.60 (-2.78%) 2438.20 2345.00 - 2438.20 0.9586 times
Wed 28 January 2026 2434.20 (3.99%) 2351.00 2331.90 - 2442.90 1.0239 times
Tue 27 January 2026 2340.80 (1.18%) 2319.00 2278.30 - 2356.20 0.6095 times
Fri 23 January 2026 2313.40 (-2.81%) 2381.90 2307.60 - 2420.00 1.1317 times
Thu 22 January 2026 2380.20 (4.46%) 2304.00 2291.30 - 2393.50 1.1581 times
Wed 21 January 2026 2278.50 (0.26%) 2270.10 2220.30 - 2299.00 1.3079 times
Tue 20 January 2026 2272.60 (-2.45%) 2329.00 2263.30 - 2337.30 1.3089 times
Mon 19 January 2026 2329.60 (-0.67%) 2345.90 2324.90 - 2354.80 0.2985 times
Fri 16 January 2026 2345.40 (-2.06%) 2409.80 2340.00 - 2409.80 0.7731 times
Wed 14 January 2026 2394.80 (1.08%) 2369.00 2361.00 - 2411.50 0.7309 times

 Daily chart GlaxosmithklinePharmaceuticals

Weekly price and charts GlaxosmithklinePharmaceuticals

Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2339.95 and 2504.55

Weekly Target 12209.67
Weekly Target 22305.63
Weekly Target 32374.2666666667
Weekly Target 42470.23
Weekly Target 52538.87

Weekly price and volumes for Glaxosmithkline Pharmaceuticals

Date Closing Open Range Volume
Fri 30 January 2026 2401.60 (3.81%) 2319.00 2278.30 - 2442.90 0.7664 times
Fri 23 January 2026 2313.40 (-1.36%) 2345.90 2220.30 - 2420.00 0.9919 times
Fri 16 January 2026 2345.40 (-1.13%) 2372.00 2337.60 - 2417.10 0.5425 times
Fri 09 January 2026 2372.10 (-4.5%) 2484.90 2350.00 - 2528.00 0.9209 times
Fri 02 January 2026 2483.80 (0.79%) 2483.00 2362.60 - 2487.70 1.8645 times
Fri 26 December 2025 2464.30 (-2.56%) 2530.10 2459.50 - 2550.10 0.4429 times
Fri 19 December 2025 2529.00 (-2.76%) 2587.70 2506.70 - 2608.90 0.8131 times
Fri 12 December 2025 2600.80 (2.17%) 2545.60 2491.00 - 2635.00 1.2725 times
Fri 05 December 2025 2545.60 (-0.93%) 2551.00 2461.10 - 2582.50 1.3186 times
Fri 28 November 2025 2569.50 (2.87%) 2497.90 2404.20 - 2585.10 1.0666 times
Fri 21 November 2025 2497.90 (0.75%) 2491.70 2471.40 - 2532.60 0.9934 times

 weekly chart GlaxosmithklinePharmaceuticals

Monthly price and charts GlaxosmithklinePharmaceuticals

Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2157.1 and 2464.8

Monthly Target 12075.6
Monthly Target 22238.6
Monthly Target 32383.3
Monthly Target 42546.3
Monthly Target 52691

Monthly price and volumes Glaxosmithkline Pharmaceuticals

Date Closing Open Range Volume
Fri 30 January 2026 2401.60 (-2.91%) 2476.00 2220.30 - 2528.00 0.5182 times
Wed 31 December 2025 2473.60 (-3.73%) 2551.00 2362.60 - 2635.00 0.8468 times
Fri 28 November 2025 2569.50 (-1.88%) 2644.00 2404.20 - 2694.00 0.7063 times
Fri 31 October 2025 2618.60 (-1.55%) 2659.70 2601.00 - 2795.90 0.4586 times
Tue 30 September 2025 2659.70 (-4.5%) 2786.00 2622.60 - 2883.40 0.7306 times
Fri 29 August 2025 2785.00 (-11.94%) 3162.90 2560.00 - 3184.30 1.0111 times
Thu 31 July 2025 3162.60 (-6.66%) 3388.70 3072.50 - 3450.00 0.6173 times
Mon 30 June 2025 3388.10 (2.71%) 3298.00 3153.90 - 3515.70 1.2351 times
Fri 30 May 2025 3298.60 (11.27%) 2935.30 2693.90 - 3398.00 2.2179 times
Wed 30 April 2025 2964.60 (2.92%) 2872.00 2401.00 - 3148.00 1.6581 times
Fri 28 March 2025 2880.35 (16.36%) 2485.00 2390.05 - 2988.00 1.1531 times

 monthly chart GlaxosmithklinePharmaceuticals

Yearly price and charts GlaxosmithklinePharmaceuticals

Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2157.1 and 2464.8

Yearly Target 12075.6
Yearly Target 22238.6
Yearly Target 32383.3
Yearly Target 42546.3
Yearly Target 52691

Yearly price and volumes Glaxosmithkline Pharmaceuticals

Date Closing Open Range Volume
Fri 30 January 2026 2401.60 (-2.91%) 2476.00 2220.30 - 2528.00 0.0779 times
Wed 31 December 2025 2473.60 (9.85%) 2235.00 1921.00 - 3515.70 2.6922 times
Tue 31 December 2024 2251.85 (18.63%) 1905.90 1842.05 - 3088.00 2.2889 times
Fri 29 December 2023 1898.15 (43.94%) 1300.00 1227.00 - 1959.00 1.2724 times
Fri 30 December 2022 1318.75 (-24.93%) 1763.00 1295.95 - 1789.90 0.739 times
Fri 31 December 2021 1756.65 (8.17%) 1607.20 1376.00 - 1918.75 0.9858 times
Thu 31 December 2020 1623.95 (0.85%) 1626.00 962.65 - 1807.50 1.1001 times
Tue 31 December 2019 1610.30 (6.27%) 1500.35 1130.00 - 1737.00 0.4706 times
Mon 31 December 2018 1515.35 (-39.13%) 2490.00 1251.00 - 3600.00 0.2393 times
Fri 29 December 2017 2489.30 (-8.81%) 2725.00 2201.20 - 2798.50 0.1338 times
Fri 30 December 2016 2729.80 (-17.15%) 3277.00 2600.00 - 3872.00 0.1341 times

Indicator Analysis of GlaxosmithklinePharmaceuticals

Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.

And this trend seems to be continuing further.

Price is above an important level of 2373.35 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.

Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.

Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO is bullish. The stock is trading above weekly resistance and downside can only be expected once it trades below 2366.7

Munafa value: 70 as on Fri 30 January 2026

This Munafa value indicates that the stock is moving upwards and might continue to move up.

SMA20 is at 2387 and price is deviating by 62 points

Upper Bollinger band is at 2509 and lower is at 2265, while middle bands are at 2326 and 2448

Price is rising

Price is above 20day SMA

Price is in lower range of bands

Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2345.94 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.

GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO

DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO

DMA period DMA value
5 day DMA 2371.32
12 day DMA 2352.23
20 day DMA 2386.69
35 day DMA 2448.27
50 day DMA 2469.01
100 day DMA 2582.25
150 day DMA 2727.37
200 day DMA 2807.42

EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO

EMA period EMA current EMA prev EMA prev2
5 day EMA2378.272366.612366.62
12 day EMA2373.322368.182368.47
20 day EMA2389.992388.772391.1
35 day EMA2422.032423.232426.56
50 day EMA2461.512463.952467.92

SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO

SMA period SMA current SMA prev SMA prev2
5 day SMA2371.322367.042349.42
12 day SMA2352.232351.862352.32
20 day SMA2386.692390.292391.17
35 day SMA2448.272452.772457.85
50 day SMA2469.012470.742473.27
100 day SMA2582.252586.752590.86
150 day SMA2727.372732.882738.25
200 day SMA2807.422808.782810.59

Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO

EPS is 56.39 and PE is: 42.59

Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)

Debt: 35.71 in crores

Market capitalization: 43709.18

EPS is 56.09 and PE is: 42.82

Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)

Debt: 9.95 in crores

Market capitalization: 47197.61

Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top